Indane

Details for Australian Patent Application No. 2006222341 (hide)

Owner Merck Patent GmbH

Inventors Zenke, Frank; Emde, Ulrich; Staehle, Wolfgang; Bruge, David; Finsinger, Dirk; Amendt, Christiane; Heiss, Nina; Schiemann, Kai; Buchstaller, HansPeter

Agent Davies Collison Cave

Pub. Number AU-B-2006222341

PCT Pub. Number WO2006/094602

Priority 10 2005 010 000.7 04.03.05 DE

Filing date 13 February 2006

Wipo publication date 14 September 2006

Acceptance publication date 2 August 2012

International Classifications

C07C 211/42 Compounds containing amino groups bound to a carbon skeleton

C07C 49/67 Ketones

C07C 211/30 Compounds containing amino groups bound to a carbon skeleton

C07D 211/70 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/96 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 239/04 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/06 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 263/04 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/094602 Priority application(s): WO2006/094602

2 August 2012 Application Accepted

  Published as AU-B-2006222341

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222350-Shelf system

2006222339-Substituted tetrahydropyrroloquinoline derivatives as kinase modulators, especially tyrosine kinase and Raf kinase modulators